Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
Voir aussi
Recommandation vaccinale
20/09/2022
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
80Yt8tgwep4M5rh9
